drugset / Trial / NCT01805453
Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma
Phase 3
Completed
80 enrolled
Assistance Publique - Hôpitaux de Paris
ANOCEF (french association of neuro-oncologists) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the efficacy of an Angiotensin-II inhibitor (Losartan) to reduce peritumoral edema in newly diagnosed glioblastoma patients.
Timeline
- Start
- 2013-03-29
- Primary completion
- 2015-01-15
- Completion
- 2017-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Losartan | Other / unclassified | 50 mg | — |